Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder CancerRoberto Contieri, Jaromír Háček, Alberto Martini et al.|European Urology Oncology|2025Cited by 11
PD29-01 THE HEMATURIA CANCER RISK SCORE: A VALIDATION STUDY DEMONSTRATING REDUCTION IN THE NUMBER NEEDED TO INVESTIGATE WHILE PRESERVING FIDELITY OF CANCER DETECTIONWei Shen Tan, John Kelly, Olayinka Gbolahan et al.|The Journal of Urology|2023Cited by 0